The excimer laser complements the ZEISS VISUMAX 800 with ZEISS SMILE pro, extending ZEISS' LVC market leadership with treatment for myopia, hyperopia, and mixed astigmatism.
Release Date: December 11, 2024For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Carl Zeiss M
Refinitiv StreetEvents Event TranscriptE D I T E D V E R S I O NAFXG.DE - Carl Zeiss Meditec AGQ4 2024 Carl Zeiss Meditec AG Earnings CallDec 11, 2024 / 09:00
Class A shares outperformed the MSCI ACWI ex-US SMID Index and the Morningstar Foreign Small/Mid Growth peer group average (11.79% for the Fund, 8% for the peer group) for Q3.
The U.S. Contact Lenses Market Size sector reached a market value of USD 3.43 billion in 2023. Future projections show a bright outlook, with a Compound Annual Growth Rate (CAGR) of 6.4% from 2023 to…